Sixty-four percent of workers experience negative emotions such as stress, anxiety, guilt or fear when requesting sick time.

The benefits industry is scrambling to adapt to a rapidly shifting regulatory and economic environment while also looking ahead to an uncertain future.

The takeaway message for employers: Wellness incentive program payments will not receive favorable tax treatment if they are not related to health care expenses, the IRS announced in a new guidance memorandum.

Novo Nordisk presented research findings on the oral version of semaglutide, the active ingredient in Ozempic and Wegovy, during the American Diabetes Association's recent scientific sessions.

Drug negotiation with manufacturers is government price fixing and is unconstitutional, says the Pharmaceutical Research and Manufacturers of America.

Higher general inflation in medical supplies and pharmaceuticals, combined with staffing issues, have increased costs for providers.

Promising new weight-loss medications can be costly -- but so is the impact of obesity on worker health and productivity.

The Custom Health Option and Individual Care Expenses (CHOICE) Arrangement Act would allow business owners to reimburse employees for individual health insurance plans - and would make that coverage portable.